Home » Iran » Page 17

Iran

Thematic sessions – Follow up to the 2019 Ministerial Declaration, 16 October

First round of thematic sessions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration Theme addressed: ‘…that both the range of drugs and drugs markets are expanding and diversifying…’. Background Note by the Secretariat Morning Session Chair: Welcome INCB [Introduction of the work of INCB] … no crimes should …

Read more

Committee of the Whole, L8. Enhancing the capacity of Member States to ensure the availability of controlled substances

OP 1 Russia: Providing assistance to states for assessing needs and necessary information to control substances for legitimate purposes, in relation to the title, we have no specific proposal we are ready to accept the title as it is on the screen. Nonetheless we would like to examine the text.  Spain: there are three separate …

Read more

Committee of the Whole, Wednesday morning / Thursday afternoon (L7. Advancing effective and innovative approaches, through national, regional, and international action, to address the multifaceted challenges posed by synthetic drugs, particularly synthetic opioids

USA: Thank you chair, we have had three sessions of informals and believe we have completed a review of the preamble so should be able to get through that but may need time or the operative paragraphs. Chair: We will now move through L7, is there any comments? Title approved. PP1 Australia: originally this pp …

Read more